Cart
sales@molnova.com
pNNP
CAS No. 330-13-2
pNNP( —— )
Catalog No. M34682 CAS No. 330-13-2
pNNP (Nitrophenylphosphate) can be used as a substrate for the PP2C assay. pNNP inhibits β-carbonic anhydrase and α-carbonate dehydrogenase, as well as H. pylori Helicobacter pylori.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 31 | In Stock |
|
| 25MG | 51 | In Stock |
|
| 50MG | 75 | In Stock |
|
| 100MG | 114 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 276 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamepNNP
-
NoteResearch use only, not for human use.
-
Brief DescriptionpNNP (Nitrophenylphosphate) can be used as a substrate for the PP2C assay. pNNP inhibits β-carbonic anhydrase and α-carbonate dehydrogenase, as well as H. pylori Helicobacter pylori.
-
DescriptionpNNP (Nitrophenylphosphate) can be used as a substrate for the PP2C assay. pNNP inhibits β-carbonic anhydrase and α-carbonate dehydrogenase, as well as H. pylori Helicobacter pylori. pNNP is a weakly active, tissue-nonspecific alkaline phosphatase modifier. pNNP has been shown to inhibit β-carbonic anhydrase and α-carbonate dehydrogenase.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetCarbonic Anhydrase
-
RecptorCarbonic Anhydrase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number330-13-2
-
Formula Weight219.09
-
Molecular FormulaC6H6NO6P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(P(=O)(O)O)C1=CC=C(N(=O)=O)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Acetazolamide
Acetazolamide is a potent carbonic anhydrase (CA) inhibitor; best-studied agent for the amelioration of acute mountain sickness (AMS).
-
Methyl 2,4-dihydroxy...
Methyl 2,4-dihydroxybenzoate is a natural product.
-
Carbonic anhydrase i...
Carbonic anhydrase inhibitor 6 is a potent human carbonic anhydrase (hCA) inhibitor that inhibits hCA IX, hCA II, hCA XII, and hCA I. It is used in the study of diseases caused by abnormalities in carbonic anhydrase.
